237 related articles for article (PubMed ID: 28231843)
21. What products are considered psychoactive under New Zealand's legal market for new psychoactive substances (NPS, 'legal highs')? Implications for law enforcement and penalties.
Rychert M; Wilkins C
Drug Test Anal; 2016 Aug; 8(8):768-78. PubMed ID: 26857892
[TBL] [Abstract][Full Text] [Related]
22. Correlates for psycho-active substance use among boarding secondary school adolescents in Enugu, South East, Nigeria.
Manyike PC; Chinawa JM; Chinawa AT; Obu HA; Nwokocha ARC; Odetunde OI
BMC Pediatr; 2016 Jun; 16():78. PubMed ID: 27282877
[TBL] [Abstract][Full Text] [Related]
23. Issues with monitoring the safety of psychoactive products under a legal regulated market for new psychoactive substances ('legal highs') in New Zealand.
Rychert M; Wilkins C; Witten K
Drug Alcohol Rev; 2017 Sep; 36(5):589-596. PubMed ID: 28229493
[TBL] [Abstract][Full Text] [Related]
24. Worldwide legislative challenges related to psychoactive drugs.
Negrei C; Galateanu B; Stan M; Balalau C; Dumitru MLB; Ozcagli E; Fenga C; Kovatsi L; Fragou D; Tsatsakis A
Daru; 2017 Jun; 25(1):14. PubMed ID: 28578694
[TBL] [Abstract][Full Text] [Related]
25. [Prevalence of new designer drugs and their legal status in Japan].
Kikura-Hanajiri R; Uchiyama N; Kawamura M; Ogata J; Goda Y
Yakugaku Zasshi; 2013; 133(1):31-40. PubMed ID: 23292017
[TBL] [Abstract][Full Text] [Related]
26. Self-reported use of novel psychoactive substances among attendees of electronic dance music venues.
Palamar JJ; Acosta P; Sherman S; Ompad DC; Cleland CM
Am J Drug Alcohol Abuse; 2016 Nov; 42(6):624-632. PubMed ID: 27315522
[TBL] [Abstract][Full Text] [Related]
27. Prevalence and correlates of substance use among undergraduates in a developing country.
Aguocha CM; Nwefoh E
Afr Health Sci; 2021 Jun; 21(2):875-883. PubMed ID: 34795747
[TBL] [Abstract][Full Text] [Related]
28. An integrated approach to care attracts people living with HIV who use illicit drugs in an urban centre with a concentrated HIV epidemic.
Fernando S; McNeil R; Closson K; Samji H; Kirkland S; Strike C; Turje RB; Zhang W; Hogg RS; Parashar S
Harm Reduct J; 2016 Nov; 13(1):31. PubMed ID: 27876048
[TBL] [Abstract][Full Text] [Related]
29. [Synthetic Drugs - An Overview of Important and Newly Emerging Substances].
Betzler F; Heinz A; Köhler S
Fortschr Neurol Psychiatr; 2016 Nov; 84(11):690-698. PubMed ID: 27846654
[No Abstract] [Full Text] [Related]
30. Psychoactive substance (drugs and alcohol) use by Emergency Department patients before injury.
Rood PP; Haagsma JA; M Boersma S; Tancica A; Van Lieshout EM; Mulligan T; Van De Mheen D; Van Beeck EF; Patka P
Eur J Emerg Med; 2016 Apr; 23(2):147-54. PubMed ID: 25093895
[TBL] [Abstract][Full Text] [Related]
31. [Prevalence and predictors of psychoactive substance use among men in prisons].
Caravaca-Sánchez F; Falcón Romero M; Luna A
Gac Sanit; 2015; 29(5):358-63. PubMed ID: 26228003
[TBL] [Abstract][Full Text] [Related]
32. Designer Drug (DD) abuse in Poland; a review of the psychoactive and toxic properties of substances found from seizures of illegal drug products and the legal consequences thereof. Part 1--cannabinoids and cathinones.
Biliński P; Hołownia P; Kapka-Skrzypczak L; Wojtyła A
Ann Agric Environ Med; 2012; 19(4):857-70. PubMed ID: 23311820
[TBL] [Abstract][Full Text] [Related]
33. Can new psychoactive substances be regulated effectively? An assessment of the British Psychoactive Substances Bill.
Reuter P; Pardo B
Addiction; 2017 Jan; 112(1):25-31. PubMed ID: 27220685
[TBL] [Abstract][Full Text] [Related]
34. New psychoactive substances legislation in Ireland - Perspectives from academia.
Kavanagh PV; Power JD
Drug Test Anal; 2014; 6(7-8):884-91. PubMed ID: 24478277
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of psychoactive drug use among drivers in Thailand: a roadside survey.
Ingsathit A; Woratanarat P; Anukarahanonta T; Rattanasiri S; Chatchaipun P; Wattayakorn K; Lim S; Suriyawongpaisal P
Accid Anal Prev; 2009 May; 41(3):474-8. PubMed ID: 19393795
[TBL] [Abstract][Full Text] [Related]
36. Raising awareness of new psychoactive substances: chemical analysis and in vitro toxicity screening of 'legal high' packages containing synthetic cathinones.
Araújo AM; Valente MJ; Carvalho M; Dias da Silva D; Gaspar H; Carvalho F; de Lourdes Bastos M; Guedes de Pinho P
Arch Toxicol; 2015 May; 89(5):757-71. PubMed ID: 24903018
[TBL] [Abstract][Full Text] [Related]
37. Methamphetamine and young men who have sex with men: understanding patterns and correlates of use and the association with HIV-related sexual risk.
Garofalo R; Mustanski BS; McKirnan DJ; Herrick A; Donenberg GR
Arch Pediatr Adolesc Med; 2007 Jun; 161(6):591-6. PubMed ID: 17548765
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of alcohol and other substances of abuse among injured patients in a Norwegian emergency department.
Bogstrand ST; Normann PT; Rossow I; Larsen M; Mørland J; Ekeberg Ø
Drug Alcohol Depend; 2011 Sep; 117(2-3):132-8. PubMed ID: 21316163
[TBL] [Abstract][Full Text] [Related]
39. 'Heads held high': an exploratory study of legal highs in pre-legislation Ireland.
Van Hout MC; Brennan R
J Ethn Subst Abuse; 2011; 10(3):256-72. PubMed ID: 21888502
[TBL] [Abstract][Full Text] [Related]
40. Cross-border activities and association with current methamphetamine use among Chinese injection drug users (IDUs) in a China-Myanmar border region.
Li L; Assanangkornchai S; Duo L; McNeil E; Li J
Drug Alcohol Depend; 2014 May; 138():48-53. PubMed ID: 24629780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
